Abstract:Streptococcus suis, an important zoonotic pathogen, has caused considerable economic losses in the swine industry and severe public health issues worldwide. The development of a novel effective strategy for the prevention and therapy of S. suis is urgently needed. Here, amentoflavone, a natural biﬂavonoid compound isolated from Chinese herbs that has negligible anti-S. suis activity, was identified as a potent antagonist of suilysin (SLY)-mediated hemolysis without interfering with the expression of SLY. Amentoflavone effectively inhibited SLY oligomerization, which is critical for its pore-forming activity. The treatment with amentoflavone reduced S. suis-induced cytotoxicity in macrophages (J774 cells). Furthermore, S. suis-infected mice that received amentoflavone exhibited lower mortality and bacterial burden. Additionally, amentoflavone significantly decreased the production of tumor necrosis factor alpha (TNF-α), interleukin-1β (IL-1β), and IL-6 in an S. suis-infected cell model. Analyses of signaling pathways demonstrated that amentoflavone reduced S. suis-induced inflammation in S. suis serotype 2 (SS2)-infected cells by regulating the p38, Jun N-terminal protein kinase 1 and 2 (JNK1/2), and NF-κB pathways. The antivirulence and anti-inflammatory properties of amentoflavone against S. suis infection provide the possibility for future pharmaceutical application of amentoflavone in the treatment of S. suis infection.IMPORTANCE The widespread use of antibiotics in therapy and in the prevention of Streptococcus suis infection in the swine industry raises concerns for the emergence of a resistant strain. The use of antivirulence agents has potential benefits, mainly because of the reduced selective pressure for the development of bacterial resistance. In this study, we found that amentoflavone is an effective agent against S. suis serotype 2 (SS2) infection both in vitro and in vivo Our results demonstrated that amentoflavone is a promising anti-infective therapeutic for S. suis infections, due to its antivirulence and anti-inflammatory effects without antibacterial activity, with fewer side effects than conventional antibacterial agents.

Paeoniflorin reduce luxS /AI-2 system-controlled biofilm formation and virulence in Streptococcus suis

Inhibitory Effect of Monoterpenoid Glycosides Extracts from Peony Seed Meal on Streptococcus suis LuxS/AI-2 Quorum Sensing System and Biofilm

BERBERINE EFFECTS BIOFILM FORMATION AND EXPRESSION OF LuxS AND VIRULENCE FACTORS IN Streptococcus Suis

Bringing Antimicrobial Strategies to a New Level: The Quorum Sensing System as a Target to Control Streptococcus suis

Sub-MICs of Azithromycin Decrease Biofilm Formation of Streptococcus suis and Increase Capsular Polysaccharide Content of S. suis

Syringa Oblata Lindl. Aqueous Extract is a Potential Biofilm Inhibitor in S. Suis

Application of a Bacteriophage Lysin to Disrupt Biofilms Formed by the Animal Pathogen Streptococcus Suis.

Effects of metformin on Streptococcus suis LuxS/AI-2 quorum sensing system and biofilm formation

Functional Analysis of Luxs in Streptococcus Suis Reveals a Key Role in Biofilm Formation and Virulence

Screening of Actinobacillus Pleuropneumoniae LuxS Inhibitors

Rutin Inhibits Streptococcus Suis Biofilm Formation by Affecting CPS Biosynthesis

Study on the Effect of Phillyrin on Streptococcus suis In Vivo and In Vitro

Inhibition of Suilysin Activity and Inflammation by Myricetin Attenuates Streptococcus Suis Virulence

Enhanced biofilm formation and reduced virulence of Actinobacillus pleuropneumoniae luxS mutant.

Crystal Structure and Identification of Two Key Amino Acids Involved in AI-2 Production and Biofilm Formation in Streptococcus Suis LuxS.

Quercetin Reduces Streptococcus Suis Virulence by Inhibiting Suilysin Activity and Inflammation

Amentoflavone Ameliorates Streptococcus Suis-Induced Infection in Vitro and in Vivo

Evaluating the Antibacterial and Antivirulence Activities of Floxuridine against Streptococcus suis

Effects of AI-2 quorum sensing related luxS gene on Streptococcus suis formatting monosaccharide metabolism-dependent biofilm

A Novel Lysin Ply1228 Provides Efficient Protection Against Streptococcus Suis Type 2 Infection in a Murine Bacteremia Model.

Theaflavin Ameliorates Streptococcus suis-Induced Infection In Vitro and In Vivo